148 related articles for article (PubMed ID: 37601690)
1. Effect of tumor-infiltrating lymphocytes depending on the presence of postmastectomy radiotherapy on the prognosis in pT1-2N1M0 breast cancer.
Zhang L; Tang T; Liu L; Li C; Li Y; Geng C
Front Oncol; 2023; 13():1175965. PubMed ID: 37601690
[TBL] [Abstract][Full Text] [Related]
2. Is it beneficial for patients with pT1-2N1M0 breast cancer to receive postmastectomy radiotherapy? An analysis based on RecurIndex assay.
Zhang L; Zhou M; Liu Y; Du F; Tang J; Wang N; Song C; Geng C; Duan H
Int J Cancer; 2021 Nov; 149(10):1801-1808. PubMed ID: 34224580
[TBL] [Abstract][Full Text] [Related]
3. [Risk-adapted postmastectomy radiotherapy based on local-regional recurrence for T1-2N1M0 breast Cancer].
Li M; Wang SL; Fang H; Tang Y; Chen B; Qi SN; Song YW; Liu YP; Lu NN; Li N; Tang Y; Ren H; Jin J; Li YX
Zhonghua Zhong Liu Za Zhi; 2017 Nov; 39(11):841-849. PubMed ID: 29151291
[No Abstract] [Full Text] [Related]
4. Tumor-infiltrating lymphocytes predict improved overall survival after post-mastectomy radiotherapy: a study of the randomized DBCG82bc cohort.
Tramm T; Vinter H; Vahl P; Özcan D; Alsner J; Overgaard J
Acta Oncol; 2022 Feb; 61(2):153-162. PubMed ID: 34705573
[TBL] [Abstract][Full Text] [Related]
5. Risk-Adapted Postmastectomy Radiotherapy Decision Based on Prognostic Nomogram for pT1-2N1M0 Breast Cancer: A Multicenter Study.
Li M; Yue J; Wan X; Hua B; Yang Q; Yang P; Zhang Z; Pei Q; Han W; Xu Y; Xia X
Front Oncol; 2020; 10():588859. PubMed ID: 33363018
[TBL] [Abstract][Full Text] [Related]
6. The prognostic differences and the effect of postmastectomy radiotherapy between post-chemotherapy ypT1-2ypN1 and de novo pT1-2N1 breast cancer.
Yang T; Zhong X; Wang J; Xiang Z; Zeng Y; Yu S; Dai Z; Xu N; Luo T; Liu L
Cancer Med; 2023 Apr; 12(7):8112-8121. PubMed ID: 36734308
[TBL] [Abstract][Full Text] [Related]
7. Effects of postmastectomy radiotherapy on prognosis in different tumor stages of breast cancer patients with positive axillary lymph nodes.
Jia MM; Liang ZJ; Chen Q; Zheng Y; Li LM; Cao XC
Cancer Biol Med; 2014 Jun; 11(2):123-9. PubMed ID: 25009754
[TBL] [Abstract][Full Text] [Related]
8. Effect of postmastectomy radiotherapy on pT
Guo XY; Sun GY; Wang HM; Liu M; Zhang YJ; Zhang N; Tang Y; Zhao XR; Jing H; Fang H; Wen G; Guo QS; Wu HF; Wang XH; Ma CY; Li YX; Cheng J; Shi M; Wang SL
Breast; 2022 Feb; 61():108-117. PubMed ID: 34942430
[TBL] [Abstract][Full Text] [Related]
9. Prognostic impact of postoperative radiotherapy in patients with breast cancer and with pT1-2 and 1-3 lymph node metastases: A retrospective cohort study based on the Japanese Breast Cancer Registry.
Yamada A; Hayashi N; Kumamaru H; Nagahashi M; Usune S; Asaga S; Iijima K; Kadoya T; Kojima Y; Kubo M; Miyashita M; Miyata H; Ogo E; Tamura K; Tanakura K; Tada K; Niikura N; Yoshida M; Ohno S; Ishikawa T; Narui K; Endo I; Imoto S; Jinno H
Eur J Cancer; 2022 Sep; 172():31-40. PubMed ID: 35752154
[TBL] [Abstract][Full Text] [Related]
10. The survival benefit of postmastectomy radiotherapy for breast cancer patients with T1-2N1 disease according to molecular subtype.
Wei J; Jiang Y; Shao Z
Breast; 2020 Jun; 51():40-49. PubMed ID: 32200207
[TBL] [Abstract][Full Text] [Related]
11. Effect of postmastectomy radiotherapy on T1-2N1M0 triple-negative breast cancer.
Xia LY; Xu WY; Zhao Y
PLoS One; 2022; 17(6):e0270528. PubMed ID: 35749525
[TBL] [Abstract][Full Text] [Related]
12. Predictive Value of Molecular Subtyping for Locoregional Recurrence in Early-Stage Breast Cancer with N1 without Postmastectomy Radiotherapy.
Wen G; Zhang JS; Zhang YJ; Zhu YJ; Huang XB; Guan XX
J Breast Cancer; 2016 Jun; 19(2):176-84. PubMed ID: 27382394
[TBL] [Abstract][Full Text] [Related]
13. Postmastectomy radiation therapy can improve survival for breast cancer patients with 1-3 positive axillary lymph nodes: a retrospective cohort study using the SEER database.
Yang J; Zhang X; Ye Y; Lin Y; Yang Q; Cai H
Transl Cancer Res; 2021 May; 10(5):1984-2001. PubMed ID: 35116521
[TBL] [Abstract][Full Text] [Related]
14. Effect of postmastectomy radiotherapy on pT1-2N1 breast cancer patients with different molecular subtypes: A real-world study based on the inverse probability of treatment weighting method.
Ye S; Hu W
Medicine (Baltimore); 2022 Sep; 101(37):e30610. PubMed ID: 36123865
[TBL] [Abstract][Full Text] [Related]
15. Practical Model to Optimize the Strategy of Adjuvant Postmastectomy Radiotherapy in T1-2N1 Breast Cancer With Modern Systemic Therapy.
Xu FF; Cao L; Xu C; Cai G; Wang SB; Qi WX; Chen JY
Front Oncol; 2022; 12():789198. PubMed ID: 35280719
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors for breast cancer patients with T1-2 tumors and 1-3 positive lymph nodes and the role of postmastectomy radiotherapy in these patients.
Zhao JM; An Q; Sun CN; Li YB; Qin ZL; Guo H; Zeng X; Zhang YT; Wei LL; Han N; Sun SC; Zhang N
Breast Cancer; 2021 Mar; 28(2):298-306. PubMed ID: 32940902
[TBL] [Abstract][Full Text] [Related]
17. The role of different lymph node staging systems in predicting prognosis and determining indications for postmastectomy radiotherapy in patients with T1-T2pN1 breast carcinoma.
Kustić D; Klarica Gembić T; Grebić D; Petretić Majnarić S; Nekić J
Strahlenther Onkol; 2020 Nov; 196(11):1044-1054. PubMed ID: 32710122
[TBL] [Abstract][Full Text] [Related]
18. Nomogram predicting survival as a selection criterion for postmastectomy radiotherapy in patients with T1 to T2 breast cancer with 1 to 3 positive lymph nodes.
Tang Y; Zhang YJ; Zhang N; Shi M; Wen G; Cheng J; Wang HM; Liu M; Wang XH; Guo QS; Wu HF; Ma CY; Jin J; Liu YP; Song YW; Fang H; Ren H; Wang SL; Li YX
Cancer; 2020 Aug; 126 Suppl 16():3857-3866. PubMed ID: 32710662
[TBL] [Abstract][Full Text] [Related]
19. Influence of age as a continuous variable on the prognosis of patients with pT1-2N1 breast cancer.
Zhao XR; Tang Y; Wu HF; Guo QS; Zhang YJ; Shi M; Cheng J; Wang HM; Liu M; Ma CY; Wen G; Wang XH; Fang H; Jing H; Song YW; Jin J; Liu YP; Chen B; Qi SN; Li N; Tang Y; Lu NN; Zhang N; Li YX; Wang SL
Breast; 2022 Dec; 66():136-144. PubMed ID: 36270084
[TBL] [Abstract][Full Text] [Related]
20. Is There a Role for Post-Mastectomy Radiotherapy for T1-2N1 Breast Cancers With Node-Positive Pathology After Patients Become Node-Negative Pathology Following Neoadjuvant Chemotherapy?
Wang Q; Zhao J; Han X; Er P; Meng X; Shi J; Sun H; Zhu J; Zhu L; Wu S; Zhang W; Sun B
Front Oncol; 2020; 10():892. PubMed ID: 32695661
[No Abstract] [Full Text] [Related]
[Next] [New Search]